A new trading day began on Monday, with Exact Sciences Corp. (NASDAQ: EXAS) stock price down -0.10% from the previous day of trading, before settling in for the closing price of $70.96. EXAS’s price has ranged from $40.62 to $79.62 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 43.88% over the last five years. Meanwhile, its annual earnings per share averaged 17.62%. With a float of $181.98 million, this company’s outstanding shares have now reached $184.77 million.
The firm has a total of 6600 workers. Let’s measure their productivity. In terms of profitability, gross margin is 72.3%, operating margin of -7.26%, and the pretax margin is -6.59%.
Exact Sciences Corp. (EXAS) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Diagnostics & Research Industry. The insider ownership of Exact Sciences Corp. is 1.51%, while institutional ownership is 97.38%. The most recent insider transaction that took place on Oct 08 ’24, was worth 65,030. In this transaction EVP, GM, Precision Oncology of this company sold 929 shares at a rate of $70.00, taking the stock ownership to the 12,758 shares. Before that another transaction happened on Oct 08 ’24, when Company’s Officer proposed sale 929 for $70.00, making the entire transaction worth $65,030.
Exact Sciences Corp. (EXAS) Recent Fiscal highlights
In its latest quarterly report, released on 6/30/2024, the company reported earnings of 0 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.07 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 17.62% per share during the next fiscal year.
Exact Sciences Corp. (NASDAQ: EXAS) Trading Performance Indicators
Here are Exact Sciences Corp.’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 1.98. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 5.01.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.96, a number that is poised to hit -0.19 in the next quarter and is forecasted to reach 0.14 in one year’s time.
Technical Analysis of Exact Sciences Corp. (EXAS)
Analysing the last 5-days average volume posted by the [Exact Sciences Corp., EXAS], we can find that recorded value of 1.34 million was lower than the volume posted last year of 2.6 million. As of the previous 9 days, the stock’s Stochastic %D was 89.50%. Additionally, its Average True Range was 2.39.
During the past 100 days, Exact Sciences Corp.’s (EXAS) raw stochastic average was set at 96.62%, which indicates a significant increase from 91.38% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 27.36% in the past 14 days, which was lower than the 59.79% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $63.35, while its 200-day Moving Average is $58.87. Now, the first resistance to watch is $71.53. This is followed by the second major resistance level at $72.17. The third major resistance level sits at $72.88. If the price goes on to break the first support level at $70.18, it is likely to go to the next support level at $69.47. Now, if the price goes above the second support level, the third support stands at $68.83.
Exact Sciences Corp. (NASDAQ: EXAS) Key Stats
With a market capitalization of 13.10 billion, the company has a total of 184,530K Shares Outstanding. Currently, annual sales are 2,500 M while annual income is -204,150 K. The company’s previous quarter sales were 699,260 K while its latest quarter income was -15,810 K.
